SE9800139D0 - New use - Google Patents

New use

Info

Publication number
SE9800139D0
SE9800139D0 SE9800139A SE9800139A SE9800139D0 SE 9800139 D0 SE9800139 D0 SE 9800139D0 SE 9800139 A SE9800139 A SE 9800139A SE 9800139 A SE9800139 A SE 9800139A SE 9800139 D0 SE9800139 D0 SE 9800139D0
Authority
SE
Sweden
Prior art keywords
new use
pain
muskuloskeletal
ropivacaine
tendinitis
Prior art date
Application number
SE9800139A
Other languages
English (en)
Swedish (sv)
Inventor
Goeran Iscasson
Dag Selander
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9800139A priority Critical patent/SE9800139D0/xx
Publication of SE9800139D0 publication Critical patent/SE9800139D0/xx
Priority to US09/254,382 priority patent/US6395291B1/en
Priority to DK99903972T priority patent/DK1054671T3/da
Priority to PT99903972T priority patent/PT1054671E/pt
Priority to AT99903972T priority patent/ATE228840T1/de
Priority to EP99903972A priority patent/EP1054671B1/en
Priority to PCT/SE1999/000012 priority patent/WO1999037301A1/en
Priority to JP2000528283A priority patent/JP4456754B2/ja
Priority to DE69904297T priority patent/DE69904297T2/de
Priority to AU24443/99A priority patent/AU2444399A/en
Priority to ES99903972T priority patent/ES2189386T3/es
Priority to US10/128,664 priority patent/US6620423B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Adornments (AREA)
SE9800139A 1998-01-21 1998-01-21 New use SE9800139D0 (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE9800139A SE9800139D0 (sv) 1998-01-21 1998-01-21 New use
ES99903972T ES2189386T3 (es) 1998-01-21 1999-01-11 Nuevo uso de ropivacaina para tratamiento del dolor.
AT99903972T ATE228840T1 (de) 1998-01-21 1999-01-11 Neue verwendung von ropivacain zur schmerzbehandlung
DK99903972T DK1054671T3 (da) 1998-01-21 1999-01-11 Ny anvendelse til smertebehandling
PT99903972T PT1054671E (pt) 1998-01-21 1999-01-11 Nova utilizacao da ropivacaina para o controlo da dor
US09/254,382 US6395291B1 (en) 1998-01-21 1999-01-11 Use for pain management
EP99903972A EP1054671B1 (en) 1998-01-21 1999-01-11 New use of ropivacaine for pain management
PCT/SE1999/000012 WO1999037301A1 (en) 1998-01-21 1999-01-11 New use for pain management
JP2000528283A JP4456754B2 (ja) 1998-01-21 1999-01-11 疼痛管理のための新規な使用
DE69904297T DE69904297T2 (de) 1998-01-21 1999-01-11 Neue verwendung von ropivacain zur schmerzbehandlung
AU24443/99A AU2444399A (en) 1998-01-21 1999-01-11 New use for pain management
US10/128,664 US6620423B2 (en) 1998-01-21 2002-04-24 Use for pain management

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9800139A SE9800139D0 (sv) 1998-01-21 1998-01-21 New use

Publications (1)

Publication Number Publication Date
SE9800139D0 true SE9800139D0 (sv) 1998-01-21

Family

ID=20409917

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9800139A SE9800139D0 (sv) 1998-01-21 1998-01-21 New use

Country Status (11)

Country Link
US (2) US6395291B1 (https=)
EP (1) EP1054671B1 (https=)
JP (1) JP4456754B2 (https=)
AT (1) ATE228840T1 (https=)
AU (1) AU2444399A (https=)
DE (1) DE69904297T2 (https=)
DK (1) DK1054671T3 (https=)
ES (1) ES2189386T3 (https=)
PT (1) PT1054671E (https=)
SE (1) SE9800139D0 (https=)
WO (1) WO1999037301A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200611217A (en) * 2005-12-06 2006-04-01 Shin Hwa Biotech Co Ltd Human model for indexing nerve paths (locus) having corresponding relations and method for indexing
US8920843B2 (en) * 2007-11-07 2014-12-30 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
US10111850B2 (en) * 2015-12-01 2018-10-30 Samuel Wilson Ester and cholinesterase inhibitor in long-acting nerve block
CA2898933A1 (en) * 2014-07-30 2016-01-30 Grigory Karmy Method for relieving chronic pain
US10751249B2 (en) * 2017-11-26 2020-08-25 Johnson Athletic Advantage LLC Trigger point dry needling in motion and method of use
BE1026845B1 (nl) 2018-12-07 2020-07-08 Fagron Compounding Services Nv Samenstelling voor gebruik in lokale infiltratie analgesie (LIA)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0151110B1 (en) 1983-08-01 1989-03-01 Astra Läkemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
SE451840B (sv) 1986-01-03 1987-11-02 Astra Laekemedel Ab Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning
SE9401174D0 (sv) 1994-04-07 1994-04-07 Astra Ab New combination
ATE219674T1 (de) 1997-03-13 2002-07-15 James N Campbell Zusammensetzung enthaltend capsaicin oder seine analogen und lokalanästhetika

Also Published As

Publication number Publication date
EP1054671B1 (en) 2002-12-04
DK1054671T3 (da) 2003-02-24
JP4456754B2 (ja) 2010-04-28
WO1999037301A1 (en) 1999-07-29
ATE228840T1 (de) 2002-12-15
US6395291B1 (en) 2002-05-28
PT1054671E (pt) 2003-03-31
US6620423B2 (en) 2003-09-16
EP1054671A1 (en) 2000-11-29
US20020156101A1 (en) 2002-10-24
DE69904297T2 (de) 2003-08-21
AU2444399A (en) 1999-08-09
JP2002501021A (ja) 2002-01-15
ES2189386T3 (es) 2003-07-01
DE69904297D1 (de) 2003-01-16

Similar Documents

Publication Publication Date Title
NZ515567A (en) Method for treating chronic pain using MEK inhibitors
DK0971713T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser
AR025964A1 (es) Tratamiento nasal topico
DE60124684D1 (de) Sulfonamido-substituierte verbrückte bicycloalkylderivative
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
AR029707A1 (es) Utilizacion de un compuesto metalo-organico para proteger y/o reforzar las materias queratinicas, y procedimiento de tratamiento
YU82602A (sh) Korišćenje il-18 inhibitora za lečenje i/ili prevenciju ateroskleroze
SE9802208D0 (sv) Novel compounds
DE60139466D1 (de) Behandlung von diabetes
FI20000635A0 (fi) COMT-inhibiittoreiden käyttö analgeettina
NO20002218D0 (no) Anvendelse av mirtazepin for behandling av søvnapne
SE9800139D0 (sv) New use
BR9808299A (pt) O uso de levobupivacaìna ou ropivacaìna para o tratamento da enxaqueca
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
SE9802209D0 (sv) Novel compounds
GB9626472D0 (en) New use of comt inhibitors
NO20005548D0 (no) Mykobakterieinhibitorer
ATE302009T1 (de) Ubichinon qn zur behandlung von migräneschmerzen
DK1042288T3 (da) Tripeptidyl-peptidase inhibitorer
DE69824862D1 (de) Zusammenstellungen zur verbesserten wundheilung
DE59910542D1 (de) Verwendung von diminazen-di-aceturat und/oder pentamidin zur behandlung von malaria
BR0206918A (pt) Uso de iloperidona
EA200000946A1 (ru) Кристаллическая форма пароксетина
NO20062138L (no) Anvendelse av ifenprodil i behandling av smerte
TR199801800T2 (xx) Uykusuzluk tedavisi.